The Experts below are selected from a list of 33 Experts worldwide ranked by ideXlab platform

Daniela Paepke - One of the best experts on this subject based on the ideXlab platform.

  • Use of biologically-based Complementary medicine in breast and gynecological cancer patients during systemic therapy
    BMC Complementary and Alternative Medicine, 2018
    Co-Authors: Loisa Drozdoff, Evelyn Klein, Marion Kiechle, Daniela Paepke
    Abstract:

    Background Biologically-based Complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy. Methods From September 2014 to December 2014 and February 2017 to May 2017 all patients ( n = 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on Complementary Medication intake during systemic therapy. Results Among 448 respondents 74.1% reported to use Complementary Medication simultaneous to their systemic therapy. The most frequently applied methods during therapy were vitamins and minerals supplements (72.3%), medicinal teas (46.7%), phytotherapy (30.1%), and mistletoe (25.3%). The analysis showed that various patients-, disease- and therapy characteristics like receiving chemotherapy ( p = 0.002), and younger age (younger than 60 years; p =0.017) are significantly associated with BB-CAM use. Conclusions Our data suggest that female cancer patients undergoing systemic therapy frequently use BB-CAM medicine. Therefore, it is indispensable to implement counseling and evidence-based Complementary treatments into clinical routine of cancer centers. A counseling service for integrative medicine concepts and an outpatient program (ZIGG) was therefore implemented in our cancer center in 2013. Further research on the CAM intake of cancer patients is needed in order to verify drug interactions and implement specific guidelines for integrative Medication concepts.

  • Use of biologically-based Complementary medicine in breast and gynecological cancer patients during systemic therapy
    BMC complementary and alternative medicine, 2018
    Co-Authors: Loisa Drozdoff, Evelyn Klein, Marion Kiechle, Daniela Paepke
    Abstract:

    Biologically-based Complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy. From September 2014 to December 2014 and February 2017 to May 2017 all patients (n= 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on Complementary Medication intake during systemic therapy. Among 448 respondents 74.1% reported to use Complementary Medication simultaneous to their systemic therapy. The most frequently applied methods during therapy were vitamins and minerals supplements (72.3%), medicinal teas (46.7%), phytotherapy (30.1%), and mistletoe (25.3%). The analysis showed that various patients-, disease- and therapy characteristics like receiving chemotherapy (p= 0.002), and younger age (younger than 60 years; p=0.017) are significantly associated with BB-CAM use. Our data suggest that female cancer patients undergoing systemic therapy frequently use BB-CAM medicine. Therefore, it is indispensable to implement counseling and evidence-based Complementary treatments into clinical routine of cancer centers. A counseling service for integrative medicine concepts and an outpatient program (ZIGG) was therefore implemented in our cancer center in 2013. Further research on the CAM intake of cancer patients is needed in order to verify drug interactions and implement specific guidelines for integrative Medication concepts.

Loisa Drozdoff - One of the best experts on this subject based on the ideXlab platform.

  • Use of biologically-based Complementary medicine in breast and gynecological cancer patients during systemic therapy
    BMC Complementary and Alternative Medicine, 2018
    Co-Authors: Loisa Drozdoff, Evelyn Klein, Marion Kiechle, Daniela Paepke
    Abstract:

    Background Biologically-based Complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy. Methods From September 2014 to December 2014 and February 2017 to May 2017 all patients ( n = 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on Complementary Medication intake during systemic therapy. Results Among 448 respondents 74.1% reported to use Complementary Medication simultaneous to their systemic therapy. The most frequently applied methods during therapy were vitamins and minerals supplements (72.3%), medicinal teas (46.7%), phytotherapy (30.1%), and mistletoe (25.3%). The analysis showed that various patients-, disease- and therapy characteristics like receiving chemotherapy ( p = 0.002), and younger age (younger than 60 years; p =0.017) are significantly associated with BB-CAM use. Conclusions Our data suggest that female cancer patients undergoing systemic therapy frequently use BB-CAM medicine. Therefore, it is indispensable to implement counseling and evidence-based Complementary treatments into clinical routine of cancer centers. A counseling service for integrative medicine concepts and an outpatient program (ZIGG) was therefore implemented in our cancer center in 2013. Further research on the CAM intake of cancer patients is needed in order to verify drug interactions and implement specific guidelines for integrative Medication concepts.

  • Use of biologically-based Complementary medicine in breast and gynecological cancer patients during systemic therapy
    BMC complementary and alternative medicine, 2018
    Co-Authors: Loisa Drozdoff, Evelyn Klein, Marion Kiechle, Daniela Paepke
    Abstract:

    Biologically-based Complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy. From September 2014 to December 2014 and February 2017 to May 2017 all patients (n= 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on Complementary Medication intake during systemic therapy. Among 448 respondents 74.1% reported to use Complementary Medication simultaneous to their systemic therapy. The most frequently applied methods during therapy were vitamins and minerals supplements (72.3%), medicinal teas (46.7%), phytotherapy (30.1%), and mistletoe (25.3%). The analysis showed that various patients-, disease- and therapy characteristics like receiving chemotherapy (p= 0.002), and younger age (younger than 60 years; p=0.017) are significantly associated with BB-CAM use. Our data suggest that female cancer patients undergoing systemic therapy frequently use BB-CAM medicine. Therefore, it is indispensable to implement counseling and evidence-based Complementary treatments into clinical routine of cancer centers. A counseling service for integrative medicine concepts and an outpatient program (ZIGG) was therefore implemented in our cancer center in 2013. Further research on the CAM intake of cancer patients is needed in order to verify drug interactions and implement specific guidelines for integrative Medication concepts.

Marion Kiechle - One of the best experts on this subject based on the ideXlab platform.

  • Use of biologically-based Complementary medicine in breast and gynecological cancer patients during systemic therapy
    BMC Complementary and Alternative Medicine, 2018
    Co-Authors: Loisa Drozdoff, Evelyn Klein, Marion Kiechle, Daniela Paepke
    Abstract:

    Background Biologically-based Complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy. Methods From September 2014 to December 2014 and February 2017 to May 2017 all patients ( n = 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on Complementary Medication intake during systemic therapy. Results Among 448 respondents 74.1% reported to use Complementary Medication simultaneous to their systemic therapy. The most frequently applied methods during therapy were vitamins and minerals supplements (72.3%), medicinal teas (46.7%), phytotherapy (30.1%), and mistletoe (25.3%). The analysis showed that various patients-, disease- and therapy characteristics like receiving chemotherapy ( p = 0.002), and younger age (younger than 60 years; p =0.017) are significantly associated with BB-CAM use. Conclusions Our data suggest that female cancer patients undergoing systemic therapy frequently use BB-CAM medicine. Therefore, it is indispensable to implement counseling and evidence-based Complementary treatments into clinical routine of cancer centers. A counseling service for integrative medicine concepts and an outpatient program (ZIGG) was therefore implemented in our cancer center in 2013. Further research on the CAM intake of cancer patients is needed in order to verify drug interactions and implement specific guidelines for integrative Medication concepts.

  • Use of biologically-based Complementary medicine in breast and gynecological cancer patients during systemic therapy
    BMC complementary and alternative medicine, 2018
    Co-Authors: Loisa Drozdoff, Evelyn Klein, Marion Kiechle, Daniela Paepke
    Abstract:

    Biologically-based Complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy. From September 2014 to December 2014 and February 2017 to May 2017 all patients (n= 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on Complementary Medication intake during systemic therapy. Among 448 respondents 74.1% reported to use Complementary Medication simultaneous to their systemic therapy. The most frequently applied methods during therapy were vitamins and minerals supplements (72.3%), medicinal teas (46.7%), phytotherapy (30.1%), and mistletoe (25.3%). The analysis showed that various patients-, disease- and therapy characteristics like receiving chemotherapy (p= 0.002), and younger age (younger than 60 years; p=0.017) are significantly associated with BB-CAM use. Our data suggest that female cancer patients undergoing systemic therapy frequently use BB-CAM medicine. Therefore, it is indispensable to implement counseling and evidence-based Complementary treatments into clinical routine of cancer centers. A counseling service for integrative medicine concepts and an outpatient program (ZIGG) was therefore implemented in our cancer center in 2013. Further research on the CAM intake of cancer patients is needed in order to verify drug interactions and implement specific guidelines for integrative Medication concepts.

Evelyn Klein - One of the best experts on this subject based on the ideXlab platform.

  • Use of biologically-based Complementary medicine in breast and gynecological cancer patients during systemic therapy
    BMC Complementary and Alternative Medicine, 2018
    Co-Authors: Loisa Drozdoff, Evelyn Klein, Marion Kiechle, Daniela Paepke
    Abstract:

    Background Biologically-based Complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy. Methods From September 2014 to December 2014 and February 2017 to May 2017 all patients ( n = 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on Complementary Medication intake during systemic therapy. Results Among 448 respondents 74.1% reported to use Complementary Medication simultaneous to their systemic therapy. The most frequently applied methods during therapy were vitamins and minerals supplements (72.3%), medicinal teas (46.7%), phytotherapy (30.1%), and mistletoe (25.3%). The analysis showed that various patients-, disease- and therapy characteristics like receiving chemotherapy ( p = 0.002), and younger age (younger than 60 years; p =0.017) are significantly associated with BB-CAM use. Conclusions Our data suggest that female cancer patients undergoing systemic therapy frequently use BB-CAM medicine. Therefore, it is indispensable to implement counseling and evidence-based Complementary treatments into clinical routine of cancer centers. A counseling service for integrative medicine concepts and an outpatient program (ZIGG) was therefore implemented in our cancer center in 2013. Further research on the CAM intake of cancer patients is needed in order to verify drug interactions and implement specific guidelines for integrative Medication concepts.

  • Use of biologically-based Complementary medicine in breast and gynecological cancer patients during systemic therapy
    BMC complementary and alternative medicine, 2018
    Co-Authors: Loisa Drozdoff, Evelyn Klein, Marion Kiechle, Daniela Paepke
    Abstract:

    Biologically-based Complementary medicines (BB-CAM) including herbs and nutritional supplements are frequently taken by breast- and gynecological cancer patients undergoing systemic therapy. The aim of this study was to analyze the use of these natural CAM methods under systemic therapy. From September 2014 to December 2014 and February 2017 to May 2017 all patients (n= 717) undergoing systemic therapy at the day care unit, Department of Gynecology and Obstetrics, Technical University Munich, Germany, with breast- and/or gynecological cancer were included in this survey. The self-administered 8-item questionnaire was developed to obtain information on Complementary Medication intake during systemic therapy. Among 448 respondents 74.1% reported to use Complementary Medication simultaneous to their systemic therapy. The most frequently applied methods during therapy were vitamins and minerals supplements (72.3%), medicinal teas (46.7%), phytotherapy (30.1%), and mistletoe (25.3%). The analysis showed that various patients-, disease- and therapy characteristics like receiving chemotherapy (p= 0.002), and younger age (younger than 60 years; p=0.017) are significantly associated with BB-CAM use. Our data suggest that female cancer patients undergoing systemic therapy frequently use BB-CAM medicine. Therefore, it is indispensable to implement counseling and evidence-based Complementary treatments into clinical routine of cancer centers. A counseling service for integrative medicine concepts and an outpatient program (ZIGG) was therefore implemented in our cancer center in 2013. Further research on the CAM intake of cancer patients is needed in order to verify drug interactions and implement specific guidelines for integrative Medication concepts.

Ashutosh Kacker - One of the best experts on this subject based on the ideXlab platform.

  • prevalence of over the counter and Complementary Medication use in the otolaryngology preoperative patient a patient safety initiative
    Laryngoscope, 2012
    Co-Authors: Manikandan Sugumaran, Justin C Cohen, Ashutosh Kacker
    Abstract:

    Objectives/Hypothesis: To determine the prevalence of over-the-counter and Complementary and alternative Medication use in the preoperative otolaryngology patient population. Study Design: Cross-sectional survey. Methods: Data were collected from preoperative surveys given to all patients undergoing surgery by a single physician with an academic practice over a 6-month period from March to September 2010. Responses were compiled and combined with demographic information obtained from the computer-based chart system. Results: A total of 92 patients, with ages ranging from 5 to 84 years old (average, 41), completed the survey. Fifty-three (58%) patients were female, and 39 (42%) were male. Forty-two (46%) patients reported the use of nonprescription Medications, and 48% reported the use of multiple Medications. Of those who reported using Medication, 11 (26%) were male and 31 (74%) were female. The average age of nonprescription Medication users was 49 years. The most commonly reported over-the-counter Medications were aspirin and ibuprofen. The most commonly reported Complementary and alternative Medications were green tea, fish oil, and vitamin E. Conclusions: The use of nonprescription Medications in the otolaryngology preoperative population is very common, especially in the female patient. The most commonly reported Medications are associated with serious potential complications, and awareness of their use is critical before the patient undergoes surgery.